Precision proton therapy aims to tame rare brain tumors with fewer side effects
NCT ID NCT02792582
First seen Nov 12, 2025 · Last updated Jun 12, 2026 · Updated 33 times
Summary
This study tests a newer form of proton therapy for people with craniopharyngioma, a rare brain tumor near the pituitary gland. The goal is to see if this precise radiation can control the tumor and cause fewer side effects than older radiation methods. The trial includes children and young adults up to age 21 whose tumor was not completely removed by surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRANIOPHARYNGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Conditions
Explore the condition pages connected to this study.